[
  {
    "title": "宣泰医药(688247.SH)：熊去氧胆酸胶囊未出现销售规模大幅增长的情况",
    "href": "http://stock.jrj.com.cn/2022/12/12212837207260.shtml",
    "datetime": "2022-12-12 21:28:06",
    "code": "688247"
  },
  {
    "title": "宣泰医药午后再度封涨停 4天涨近110%",
    "href": "http://stock.jrj.com.cn/2022/12/12140537205448.shtml",
    "datetime": "2022-12-12 14:05:42",
    "code": "688247"
  },
  {
    "title": "粘上防疫就大涨！口罩、退烧药都涨疯了，宣泰医药继续大涨17%；碧桂园服务大跌16%，控股股东套现50",
    "href": "http://stock.jrj.com.cn/2022/12/12125737205257.shtml",
    "datetime": "2022-12-12 12:57:00",
    "code": "688247"
  },
  {
    "title": "最新龙虎榜：机构买入明泰铝业超1亿，知名游资买入宣泰医药",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/12075437204279.shtml",
    "datetime": "2022-12-12 07:54:03",
    "code": "688247"
  },
  {
    "title": "本周十大牛熊股：熊去氧胆酸概念股宣泰医药、新华制药领跑，粤传媒“风光不再”",
    "href": "http://stock.jrj.com.cn/invest/2022/12/11173237203948.shtml",
    "datetime": "2022-12-11 17:32:47",
    "code": "688247"
  },
  {
    "title": "宣泰医药：公司熊去氧胆酸胶囊产品不涉及新冠病毒预防及感染的治疗",
    "href": "http://stock.jrj.com.cn/2022/12/08174737198857.shtml",
    "datetime": "2022-12-08 17:47:27",
    "code": "688247"
  },
  {
    "title": "熊去氧胆酸概念继续走强，宣泰医药2连板",
    "href": "http://stock.jrj.com.cn/2022/12/08094437197120.shtml",
    "datetime": "2022-12-08 09:44:31",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：公司熊去氧胆酸胶囊产品不涉及新冠病毒预防及感染的治疗",
    "href": "http://stock.jrj.com.cn/2022/12/07164737195248.shtml",
    "datetime": "2022-12-07 16:47:07",
    "code": "688247"
  },
  {
    "title": "宣泰医药：近日熊去氧胆酸用于预防新冠病毒感染的研究报道，尚未进行验证性临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/07163137195101.shtml",
    "datetime": "2022-12-07 16:31:37",
    "code": "688247"
  },
  {
    "title": "宣泰医药股东宁波栖和质押700万股 用于融资",
    "href": "http://stock.jrj.com.cn/2022/11/02201137107740.shtml",
    "datetime": "2022-11-02 20:11:43",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：第三季度净利增11.88%至2689.84万元",
    "href": "http://stock.jrj.com.cn/2022/10/26175737086349.shtml",
    "datetime": "2022-10-26 17:57:38",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：拟使用额度不超3.5亿元部分闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/09/09154036986214.shtml",
    "datetime": "2022-09-09 15:40:27",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247)：将于2022年8月25日在上海证券交易所科创板上市",
    "href": "http://stock.jrj.com.cn/2022/08/24085636928905.shtml",
    "datetime": "2022-08-24 08:56:55",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：将于8月25日在上交所科创板上市",
    "href": "http://stock.jrj.com.cn/2022/08/23190936927389.shtml",
    "datetime": "2022-08-23 19:09:53",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247)：披露网上发行中签结果",
    "href": "http://stock.jrj.com.cn/2022/08/18091436910563.shtml",
    "datetime": "2022-08-18 09:14:06",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：海通创新证投获配226.7万股、网上摇号中签号共25844个",
    "href": "http://stock.jrj.com.cn/2022/08/17190636909131.shtml",
    "datetime": "2022-08-17 19:06:42",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247)：网上发行中签率为 0.03366050%",
    "href": "http://stock.jrj.com.cn/2022/08/17091336906654.shtml",
    "datetime": "2022-08-17 09:13:18",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)：回拨后网上发行中签率为0.03366050%",
    "href": "http://stock.jrj.com.cn/2022/08/16190736905447.shtml",
    "datetime": "2022-08-16 19:07:49",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247)：发行价格确定9.37元/股，发行日期2022年8月16日（T日）",
    "href": "http://stock.jrj.com.cn/2022/08/15091036898759.shtml",
    "datetime": "2022-08-15 09:10:42",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247.SH)IPO定价9.37元/股 8月16日开启申购",
    "href": "http://stock.jrj.com.cn/2022/08/14180636897878.shtml",
    "datetime": "2022-08-14 18:06:38",
    "code": "688247"
  },
  {
    "title": "宣泰医药(688247)：首发4534万股，询价日期为2022年8月11日周四",
    "href": "http://stock.jrj.com.cn/2022/08/08091436877667.shtml",
    "datetime": "2022-08-08 09:14:48",
    "code": "688247"
  },
  {
    "title": "宣泰医药：核心产品独木难支 业绩藏变脸风险",
    "href": "http://stock.jrj.com.cn/ipo/2022/04/20160836409821.shtml",
    "datetime": "2022-04-20 16:08:20",
    "code": "688247"
  },
  {
    "title": "首次上会遭暂缓审议迎二次上会，宣泰医药科创板IPO再闯关成功",
    "href": "http://stock.jrj.com.cn/2022/01/12085934148495.shtml",
    "datetime": "2022-01-12 08:59:24",
    "code": "688247"
  },
  {
    "title": "宣泰医药成今年IPO暂缓审议第13家 保荐机构海通证券",
    "href": "http://stock.jrj.com.cn/2021/11/12094533839980.shtml",
    "datetime": "2021-11-12 09:45:00",
    "code": "688247"
  },
  {
    "title": "宣泰医药科创板IPO遭暂缓审议，荣昌生物成功过审",
    "href": "http://stock.jrj.com.cn/2021/11/12090933839763.shtml",
    "datetime": "2021-11-12 09:09:41",
    "code": "688247"
  },
  {
    "title": "去年净利润数据前后“打脸”，宣泰医药科创板IPO上会前夕业绩下滑",
    "href": "http://stock.jrj.com.cn/2021/11/05131033816462.shtml",
    "datetime": "2021-11-05 13:10:21",
    "code": "688247"
  },
  {
    "title": "因财报更新事宜，宣泰医药科创板IPO中止审核",
    "href": "http://stock.jrj.com.cn/2021/11/02092233801983.shtml",
    "datetime": "2021-11-02 09:22:43",
    "code": "688247"
  },
  {
    "title": "终端销售情况不佳经销商每年却增加囤货数量？宣泰医药回科创板二轮问询",
    "href": "http://stock.jrj.com.cn/2021/09/08130833403416.shtml",
    "datetime": "2021-09-08 13:08:18",
    "code": "688247"
  },
  {
    "title": "专利数量是否满足科创属性相关要求？宣泰医药科创板IPO首轮问询连遭20问",
    "href": "http://stock.jrj.com.cn/2021/08/09114733224685.shtml",
    "datetime": "2021-08-09 11:47:58",
    "code": "688247"
  },
  {
    "title": "新进展！宣泰医药冲刺科创板IPO进入“已问询”阶段",
    "href": "http://stock.jrj.com.cn/2021/06/11103032909972.shtml",
    "datetime": "2021-06-11 10:30:01",
    "code": "688247"
  },
  {
    "title": "宣泰医药闯关科创板 核心产品占营收近八成",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/24083832805084.shtml",
    "datetime": "2021-05-24 08:38:51",
    "code": "688247"
  },
  {
    "title": "产品品种有限 两股东突击入股能否助力宣泰医药科创板IPO？",
    "href": "http://stock.jrj.com.cn/2021/05/21091432791646.shtml",
    "datetime": "2021-05-21 09:14:57",
    "code": "688247"
  }
]